Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$586,205,394
+$29,639,951 QoQ
Shares Held
6,027,819
-13.7% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 90.70269030971235.ToString("F0")%
None 9.297309690287648.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,771 across 180 Biotechnology names. RVMD ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
This page
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $586,205,394 | 6,027,819 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $556,565,443 | 6,987,639 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $458,287,457 | 9,813,436 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $377,455,758 | 10,259,738 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $416,820,883 | 11,787,921 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $473,340,759 | 10,821,691 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $517,053,214 | 11,401,394 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $530,152,202 | 13,660,196 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $474,255,615 | 14,714,726 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $426,818,222 | 14,882,086 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $292,646,104 | 10,572,475 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $275,249,177 | 10,289,689 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $225,813,467 | 10,425,368 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $211,378,056 | 8,873,974 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $145,556,846 | 7,381,179 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $120,233,844 | 6,169,002 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $104,182,556 | 4,083,989 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $113,539,223 | 4,510,895 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $124,815,673 | 4,537,102 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $177,078,981 | 5,579,048 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $179,879,327 | 3,920,648 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,192,440 | 232,191 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,093,596 | 203,839 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,926,130 | 282,741 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,376,329 | 336,665 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||